TCL Archive New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy December 31, 2004
TCL Archive NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units March 1, 2013
TCL Archive Also in this 8-page issue: NIH Conflict of Interest panel recommends that NIH employees should not receive stock options or equities as compensation for outside work. May 7, 2004
TCL Archive New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet, January 19, 2007
